共 176 条
[1]
Ajani JA(1994)Activity of taxol in patients with squamous cell carcinoma and adenocarcinoma of the esophagus J Natl Cancer Inst 86 1086-1091
[2]
Ilson DH(1997)In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human ovarian cancers Cancer Chemother Pharmacol 39 493-497
[3]
Daugherty K(1997)Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer Eur J Cancer 33 1216-1220
[4]
Pazdur R(2005)Bi-weekly chemotherapy of paclitaxel and cisplatin in patients with metastatic or recurrent esophageal cancer J Korean Med Sci 20 618-623
[5]
Lynch PM(2008)Capecitabine and oxaliplatin for advanced esophagogastric cancer N Engl J Med 358 36-46
[6]
Kelsen DP(2004)A phase II study of carboplatin and paclitaxel in esophageal cancer Ann Oncol 15 960-965
[7]
Alberts DS(1992)Phase II evaluation of cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the esophagus: a Japanese Esophageal Oncology Group Trial Jpn J Clin Oncol 22 172-176
[8]
Fanta PT(1998)Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus J Clin Oncol 16 1826-1834
[9]
Running KL(1999)Phase II trial of weekly irinotecan plus cisplatin in advanced esophageal cancer J Clin Oncol 17 3270-3275
[10]
Adair LP(2007)Paclitaxel given by a weekly 1-h infusion in advanced esophageal cancer Ann Oncol 18 898-902